UNIGE document Scientific Article
previous document  unige:748  next document
add to browser collection
Title

Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva)

Authors
Masouyé, Isabelle
Published in Dermatology. 2008, vol. 216, no. 3, p. 247-9
Abstract Erlotinib is a small molecule tyrosine kinase inhibitor that is used as an anticancer agent. Most patients develop a pustular facial dermatitis within the first week of treatment. Pyogenic granulomas of the nail folds are another typical adverse event occurring in about 10-15% of cases. We report on a patient who developed a generalized dermatitis characterized by neutrophilic spongiosis. Neutrophilic inflammation has been observed in several drugs that interfere with EGFR signaling, suggesting a class effect. The present case may be yet another manifestation of this particular reaction pattern.
Keywords Antineoplastic Agents/adverse effectsCarcinoma Renal Cell/drug therapy/secondaryDermatitis/etiology/pathologyDrug Eruptions/etiology/pathologyFemaleHumansKidney Neoplasms/drug therapy/pathologyMiddle AgedNeutrophilsProtein Kinase Inhibitors/adverse effectsQuinazolines/adverse effectsReceptor Epidermal Growth Factor/antagonists & inhibitorsSkin/pathology
Identifiers
PMID: 18182820
Full text
Structures
Research group Immunothérapie des cancers (42)
Citation
(ISO format)
LUBBE, Jann, MASOUYÉ, Isabelle, DIETRICH, Pierre-Yves. Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva). In: Dermatology, 2008, vol. 216, n° 3, p. 247-9. https://archive-ouverte.unige.ch/unige:748

192 hits

1 download

Update

Deposited on : 2009-02-11

Export document
Format :
Citation style :